DSM €765 million acquisition of Glycom

31/3/2020

Private acquisition

Value:

€ 765 million

Dollar value:

$ 847 million

Status:

Completed

Date:

31/3/2020

Overview:

Royal DSM, a Dutch nutrition, health and sustainable living solutions provider has acquired the Denmark-based biotech company Glycom.
Valued at €765 million, Glycom is a supplier of Human Milk Oligosaccharides (HMOs) and will allow DSM to expand its early life nutrition solutions portfolio.

Natasha Forrest - Researcher

Jurisdiction:

Denmark

Deal type:

Private acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences

Firms:

Accura

Party: Royal DSM (Acquirer)

Lawyers: Mads Ilum, Thomas Weincke

Kromann Reumert

Party: Nestlé (Shareholder)

Party: Danica (Shareholder)

Lawyers: Bent Kemplar, Oliver Machholdt

Related deals